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Photodynamic therapy with m-THPC (Foscan) is as
established treatment for superficial squamous cell carci-
noma and is also being considered for treatment of
larger head and neck tumors. Recently, clinical imple-
mentation of Foscan-mediated PDT in the head and
neck has not been optimal; a subset of patients has
experienced incomplete response. It is well-understood
that sufficient quantities of light, drug and oxygen must
be present in the targeted tissue in order to deliver suffi-
cient damage. This requirement is complicated by varia-
tions in the tissue optical properties and in the
photosensitizer uptake rates; however, most clinical
protocols do not measure the affect of these factors on
the PDT dose delivered to individual patients.
This study represents a first step toward incorporating
optical techniques developed to monitor PDT treat-
ments in pre-clinical models into the clinical treatment
of head and neck cancer. This clinical study incorpo-
rates reflectance and fluorescence spectroscopic
measurements are into the PDT-treatment protocol.
Spectral analysis allows the extraction of Foscan concen-
trations and the quantitative determination of tissue
physiological parameters that are important to the PDT-
delivered dose (e.g. blood volume and hemoglobin
saturation). The study identifies the practical and techni-
cal challenges of translating these techniques into the
clinical setting. Moreover, the data presented here
contribute to understanding the link between these
optical measurements and the PDT-dose delivered to
individual patients during treatment.
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